Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2232-2238

  Hirsch, Irl B ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN DERIVATIVE;

ACCURACY; ADULT; ALARM MONITORING; COST; DEVICE; DIABETES CONTROL; ENDOCRINOLOGY; EXPECTATION; EXPERIENCE; FEMALE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HEALTH INSURANCE; HOME MONITORING; HUMAN; INFORMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; MEDICAL SPECIALIST; MEDLINE; OFFICE WORKER; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT SELECTION; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; TECHNOLOGY; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; ECONOMICS; EVALUATION; INSTRUMENTATION; INSULIN INFUSION; METHODOLOGY; PATIENT EDUCATION; PHYSICIAN ATTITUDE; UTILIZATION REVIEW;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; ENDOCRINOLOGY; HUMANS; INSULIN INFUSION SYSTEMS; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PHYSICIAN'S ROLE;

EID: 67650248749     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2625     Document Type: Review

References (18)

1. Guerci B, Floriot M, Böhme P, Durain D, Benichou M, Jellimann S, Drouin P 2003 Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 26:582-589
2. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J 2004 Use of the continuous glucose monitoring system to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 79:1521-1526
3. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA 2008 Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 10:377-383
4. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D 2008 Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359:1464-1476
5. Tamborlane WV, Beck RV, Laffel L 2009 Continuous glucose monitoring and type 1 diabetes. N Engl J Med (letter) 360:190-192
6. Feldman B, Brazg R, Schwartz S, Weinstein R 2003 A continuous glucose sensor based on wired enzyme technology-results from a 3-day trial in patients with diabetes. Diabetes Technol Ther 5:769-779
7. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ 1999 Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 277:E561-E571
8. Kovatchev B, Anderson S, Heinemann L, Clarke W 2008 Comparison of the clinical and numerical accuracy of 4 continuous glucose monitors. Diabetes Care 31:1160-1164
9. 2003 In vitro diagnostic test systems requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Publication no. 15197. Geneva: International Organization for Standardization
10. Brauker J, Matsubara B 2008 Comparison of the numerical and clinical accuracy of four continuous glucose monitors - response to Kovatchev et al. Diabetes Care 31:e80
11. Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb PA 2009 Comparison and accuracy of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther 11:65-72
12. Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H 2008 Clinical application of emerging sensor technologies in diabetes management. Consensus guidelines for continuous glucose monitoring. Diabetes Technol Ther 10:232-244; quiz 245-246
13. Hirsch IB 2005 Insulin analogues. N Engl J Med 352:174-183
14. Hirsch IB 2004 Blood glucose monitoring technology: translating data into practice. Endocr Pract 10:67-76
15. Skyler JS 1997 Tactics for type 1 diabetes. Endocrinol Metab Clin North Am 26:647-657
16. Brauker J, Kamath A, Li Y, Zisser H, Schwartz S, Ratner R, Wise J, Bailey T 2007 Time lag of a seven-day transcutaneous glucose sensor compared to YSI blood glucose values. Diabetes 56(Suppl 1):A119
17. Hirsch IB, Bode BW, Childs BP, Close KL, Fisher WA, Gavin JR, Ginsberg BH, Raine CH, Verderese CA 2008 Self-monitoring of blood glucose (SMBG) in insulin- and non-insulin using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research. Diabetes Technol Ther 10:419-439
18. Garg SK, Voelmle MK, Gottlieb P 2009 Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetes. Diabetes Care 32:436-438